万古霉素骨蜡不降低心脏手术后深部胸骨伤口感染发生率
该单中心回顾性研究纳入2003至2015年接受冠脉搭桥、瓣膜或联合手术的14492例患者,深部胸骨伤口感染(DSWI)总体发生率为0.9%。多因素分析显示万古霉素骨蜡涂抹胸骨边缘与DSWI发生率降低无关,尽管研究期间DSWI发生率下降,但同期实施了修订的STS抗生素给药指南等策略。
要点
- 万古霉素骨蜡局部应用未降低心脏手术后DSWI风险。
- DSWI总体发生率为0.9%,研究期间发生率下降。
- BMI、NYHA分级和STS DSWI风险指数与DSWI显著相关。
核心结论
- 万古霉素骨蜡应用于胸骨边缘与心脏手术后DSWI风险降低无关。
研究设计与样本
- 单中心回顾性研究,纳入2003至2015年接受冠脉搭桥、瓣膜或联合手术的14492例患者。
主要发现
- 14492例患者中136例发生DSWI,总体发生率为0.9%。
- 多因素分析显示BMI、NYHA功能分级和STS DSWI风险指数与DSWI显著相关。
- 尽管DSWI发生率随时间下降,万古霉素骨蜡使用与DSWI发生率降低无关。
临床怎么用
- 不应依赖万古霉素骨蜡作为降低DSWI的常规措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deep sternal wound infection (DSWI) is a devastating complication that increases morbidity and death in cardiac surgical patients. Vancomycin is often administered intravenously for antibiotic prophylaxis in cardiac operations. Many cardiac surgeons also apply vancomycin paste topically to the sternal edges. We examined the effect of vancomycin paste on the incidence of DSWI in patients undergoing elective cardiac operations. METHODS: We retrospectively reviewed the medical records of all patients from 2003 to 2015 who underwent coronary artery bypass grafting, valve, or combined coronary artery bypass grafting and valve operations at a single institution. We derived The Society for Thoracic Surgeons (STS) DSWI risk index for each patient and systematically reviewed operative, pharmacy, microbiology, and discharge records to document DSWI in these patients. Multivariate analyses were used to identify predictors of DSWI in this cohort and to quantify the effect of vancomycin paste. RESULTS: Of the 14,492 patients whose records we examined, DSWI developed in 136 patients, resulting in an overall incidence of 0.9%. After multivariate analysis, body mass index, New York Heart Association Functional Classification, and the STS DSWI risk index remained statistically significant and associated with DSWI. Although the incidence of DSWI decreased over time, the use of vancomycin paste was not associated with a reduced incidence of DSWI. CONCLUSIONS: There was a marked decrease in the incidence of DSWI during the study period, concurrent with institutional implementation of revised STS antibiotic dosing guidelines in 2007 and other strategies. However, the application of vancomycin paste to the sternal edges of patients undergoing cardiac operations was not associated with a reduced risk of DSWI.
引用
- Lander HL, Ejiofor JI, McGurk S, et al. Vancomycin Paste Does Not Reduce the Incidence of Deep Sternal Wound Infection After Cardiac Operations. Ann Thorac Surg. 2016. PMID: 28027730. doi:10.1016/j.athoracsur.2016.10.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。